tiprankstipranks
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Hong Kong Market
2126
JW (Cayman) Therapeutics Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:2126 full AI Analyst Report?

JW (Cayman) Therapeutics Co. Ltd. (2126) Financial Statements

0 Followers

JW (Cayman) Therapeutics Co. Ltd. Financial Overview

JW (Cayman) Therapeutics Co. Ltd.'s market cap is currently HK$858.46M. The company's EPS TTM is HK$-1.32; its P/E ratio is -1.73; JW (Cayman) Therapeutics Co. Ltd. is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 276.31M¥ 158.22M¥ 173.86M¥ 145.70M¥ 30.80M
Gross Profit¥ 118.91M¥ 77.32M¥ 88.22M¥ 58.76M¥ 9.04M
Operating Income¥ -241.71M¥ -459.28M¥ -789.61M¥ -855.88M¥ -759.08M
EBITDA¥ -161.95M¥ -381.58M¥ -655.75M¥ -752.27M¥ -738.70M
Net Income¥ -540.92M¥ -590.62M¥ -768.00M¥ -846.13M¥ -702.33M
Balance Sheet
Cash & Short-Term Investments¥ 503.28M¥ 762.53M¥ 1.01B¥ 1.39B¥ 1.84B
Total Assets¥ 987.32M¥ 1.68B¥ 2.15B¥ 2.79B¥ 3.12B
Total Debt¥ 262.67M¥ 422.40M¥ 318.80M¥ 279.13M¥ 147.03M
Net Debt¥ -240.61M¥ -334.97M¥ -687.11M¥ -1.10B¥ -1.69B
Total Liabilities¥ 430.82M¥ 511.20M¥ 462.26M¥ 437.06M¥ 325.75M
Stockholders' Equity¥ 556.50M¥ 1.17B¥ 1.68B¥ 2.35B¥ 2.79B
Cash Flow
Free Cash Flow¥ -78.46M¥ -348.87M¥ -413.00M¥ -613.60M¥ -634.28M
Operating Cash Flow¥ -76.85M¥ -333.44M¥ -398.42M¥ -536.72M¥ -561.20M
Investing Cash Flow¥ -1.49M¥ -15.43M¥ 9.90M¥ -124.08M¥ -137.13M
Financing Cash Flow¥ -169.81M¥ 90.49M¥ 275.00K¥ 112.35M¥ -30.62M
Currency in CNY

JW (Cayman) Therapeutics Co. Ltd. Earnings and Revenue History

Income Statement >

JW (Cayman) Therapeutics Co. Ltd. Debt to Assets

Balance Sheet >

JW (Cayman) Therapeutics Co. Ltd. Cash Flow

Cash Flow >

JW (Cayman) Therapeutics Co. Ltd. Forecast EPS vs Actual EPS

Earnings >